Efficacy and safety of regorafenib versus dinutuximab with chemotherapy in Chinese children with neuroblastoma
The objective of the present study was to evaluate the efficacy and safety of regorafenib in comparison with dinutuximab with chemotherapy in Chinese children with advanced neuroblastoma. The patients aged less than 16 years who were histologically diagnosed with advanced neuroblastoma were enrolled...
Saved in:
Main Authors: | Kun Dong (Author), Guan Wang (Author), Zeng Liang Wang (Author), Xueyan Wang (Author) |
---|---|
Format: | Book |
Published: |
Bangladesh Pharmacological Society,
2019-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Efficacy and safety of regorafenib versus dinutuximab with chemotherapy in Chinese children with neuroblastoma
by: Kun Dong, et al.
Published: (2019) -
Early Use of Dinutuximab Beta in Patients with High-Risk Neuroblastoma
by: Neofit Spasov, et al.
Published: (2021) -
Clinical Presentation and Management of a Dinutuximab Beta Extravasation in a Patient with Neuroblastoma
by: Michael Launspach, et al.
Published: (2021) -
Dinutuximab Beta in Children with High-Risk Neuroblastoma: Experience from a Single Center in Croatia
by: Jasminka Stepan Giljević, et al.
Published: (2022) -
Impact of IL-2 on Treatment Tolerance in Patients With High-Risk Neuroblastoma Treated With Dinutuximab Beta-Based Immunotherapy
by: Filiz Cicek, et al.
Published: (2020)